March 13, 2025
Crown Bioscience Appoints John Gu as Chief Executive Officer
February 17, 2025
Crown Bioscience Completes Merger with Indivumed Services
February 11, 2025
Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation
December 11, 2024
Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership
December 10, 2024
Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation
December 12, 2024
Translating In Vitro and In Vivo Multi-Omics Oncology Data to Enhance Early Biomarker Discovery
October 30, 2024
Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test
October 1, 2024
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
August 21, 2024
Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development
May 24, 2024
Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center
May 23, 2024
Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies
US Tel: +1 858 622 2900
UK Tel: +44 870 242 2900
All Contact Information
4 minute read
October 24, 2019
September 19, 2019
5 minute read
September 17, 2019
September 13, 2019
September 11, 2019
August 22, 2019
6 minute read
August 20, 2019
7 minute read
August 15, 2019
August 8, 2019
3 minute read
July 26, 2019
2025-03-03
2022-12-16
